Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06442241 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults

StatusActive, Not Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 13, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Feb 2025 to Dec 30, 2025v3 Show 4 more changesShow less
    • Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Study sites: 0 to 1
    • Study completion date: Apr 2025 to Dec 30, 2025
    • Start date changed from estimate of Jul 2024 to Jul 31, 2024
  2. Study completion date: Feb 2025 to Apr 2025
    • Eligibility criteria expanded, about 53 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A phase 1, randomized, observer-blinded, parallel-controlled, dose escalation study in Australia will evaluate the safety and immunogenicity of the RSV vaccine candidate LYB005 with or without adjuvant in healthy adults aged 18 years and older.
Trial Details
NCT Number NCT06442241
Lead Sponsor Guangzhou Patronus Biotech Co., Ltd.
Collaborators: Yantai Patronus Biotech Co., Ltd.
Conditions
(from sponsor)		 Respiratory Syncytial Virus (RSV), RSV Infection
Related terms Respiratory Syncytial Virus Infections
Enrollment 84 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov